Revenues Not Telling The Story For Grown Rogue International Inc. (CSE:GRIN) After Shares Rise 27%
Jul 15
Have your own idea? Try our Stock Screener
Canadian (TSX) Healthcare Sector Analysis
UpdatedJul 15, 2025
DataAggregated Company Financials
Companies127
- 7D4.2%
- 3M13.4%
- 1Y-21.3%
- YTD-9.2%
Over the last 7 days, the Healthcare industry has risen 4.2%, driven by gains in Curaleaf Holdings and Green Thumb Industries of 35% and 17%, respectively. Meanwhile, ME Therapeutics Holdings actually underperformed within the industry, shrinking 47% in the last week. In contrast, the industry has lost 21% in the last 12 months. Looking forward, earnings are forecast to grow by 43% annually.
Sector Valuation and Performance
Has the Canadian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 16 Jul 2025 | CA$29.1b | CA$19.5b | -CA$2,791,689,536.61 | 23.7x | -10.4x | 1.5x |
| Fri, 13 Jun 2025 | CA$27.4b | CA$19.4b | -CA$2,802,095,382.92 | 22.7x | -9.8x | 1.4x |
| Sun, 11 May 2025 | CA$27.6b | CA$19.6b | -CA$2,765,000,320.56 | 26.2x | -10x | 1.4x |
| Tue, 08 Apr 2025 | CA$24.5b | CA$19.9b | -CA$2,834,815,518.08 | 17.9x | -8.6x | 1.2x |
| Thu, 06 Mar 2025 | CA$27.2b | CA$20.1b | -CA$2,712,500,068.92 | 23.8x | -10x | 1.4x |
| Sat, 01 Feb 2025 | CA$28.5b | CA$19.9b | -CA$2,686,059,656.72 | 27.4x | -10.6x | 1.4x |
| Mon, 30 Dec 2024 | CA$28.5b | CA$19.8b | -CA$2,735,157,708.42 | 25.1x | -10.4x | 1.4x |
| Wed, 27 Nov 2024 | CA$29.6b | CA$19.8b | -CA$2,838,034,566.26 | 19.7x | -10.4x | 1.5x |
| Fri, 25 Oct 2024 | CA$35.7b | CA$19.5b | -CA$2,979,281,528.91 | 20.7x | -12x | 1.8x |
| Sun, 22 Sep 2024 | CA$32.2b | CA$19.3b | -CA$2,973,143,203.87 | 21.4x | -10.8x | 1.7x |
| Tue, 20 Aug 2024 | CA$33.8b | CA$19.2b | -CA$3,013,142,353.67 | 22.6x | -11.2x | 1.8x |
| Thu, 18 Jul 2024 | CA$34.0b | CA$19.1b | -CA$3,657,226,275.63 | 19.5x | -9.3x | 1.8x |
| Sat, 15 Jun 2024 | CA$33.0b | CA$19.3b | -CA$3,323,512,457.31 | 17.1x | -9.9x | 1.7x |
| Mon, 13 May 2024 | CA$36.4b | CA$19.5b | -CA$3,920,170,048.31 | 16.5x | -9.3x | 1.9x |
| Wed, 10 Apr 2024 | CA$37.9b | CA$19.4b | -CA$4,048,764,809.23 | 13.5x | -9.4x | 2x |
| Fri, 08 Mar 2024 | CA$31.3b | CA$19.2b | -CA$4,432,856,856.45 | 15.3x | -7.1x | 1.6x |
| Sun, 04 Feb 2024 | CA$40.1b | CA$20.1b | -CA$7,652,126,077.00 | 13.8x | -5.2x | 2x |
| Tue, 02 Jan 2024 | CA$33.3b | CA$19.9b | -CA$7,637,721,760.00 | 14.2x | -4.4x | 1.7x |
| Thu, 30 Nov 2023 | CA$33.3b | CA$20.1b | -CA$7,859,207,180.00 | 15.4x | -4.2x | 1.7x |
| Sat, 28 Oct 2023 | CA$29.3b | CA$20.1b | -CA$8,447,932,806.00 | 17.2x | -3.5x | 1.5x |
| Mon, 25 Sep 2023 | CA$35.4b | CA$20.5b | -CA$8,941,314,525.00 | 17.8x | -4x | 1.7x |
| Wed, 23 Aug 2023 | CA$29.3b | CA$20.6b | -CA$9,115,768,672.00 | 18.9x | -3.2x | 1.4x |
| Fri, 21 Jul 2023 | CA$31.0b | CA$20.5b | -CA$10,780,860,062.00 | 21.2x | -2.9x | 1.5x |
| Sun, 18 Jun 2023 | CA$30.1b | CA$20.5b | -CA$10,505,717,668.00 | 18.5x | -2.9x | 1.5x |
| Tue, 16 May 2023 | CA$30.4b | CA$20.7b | -CA$11,403,268,446.00 | 16.1x | -2.7x | 1.5x |
| Thu, 13 Apr 2023 | CA$48.3b | CA$21.5b | -CA$11,319,735,607.00 | 16.3x | -4.3x | 2.2x |
| Sat, 11 Mar 2023 | CA$33.4b | CA$22.1b | -CA$12,048,153,552.00 | 21.6x | -2.8x | 1.5x |
| Mon, 06 Feb 2023 | CA$36.3b | CA$21.9b | -CA$11,561,849,458.00 | 19.3x | -3.1x | 1.7x |
| Wed, 04 Jan 2023 | CA$34.3b | CA$22.1b | -CA$11,592,644,744.00 | 18.9x | -3x | 1.6x |
| Fri, 02 Dec 2022 | CA$46.5b | CA$21.8b | -CA$11,673,127,320.00 | 20.2x | -4x | 2.1x |
| Sun, 30 Oct 2022 | CA$41.9b | CA$21.3b | -CA$10,834,484,677.00 | 21.1x | -3.9x | 2x |
| Tue, 27 Sep 2022 | CA$39.9b | CA$21.4b | -CA$10,877,964,552.00 | 22.1x | -3.7x | 1.9x |
| Thu, 25 Aug 2022 | CA$48.4b | CA$20.8b | -CA$10,454,884,946.00 | 23.1x | -4.6x | 2.3x |
| Sat, 23 Jul 2022 | CA$46.5b | CA$19.7b | -CA$7,319,052,088.00 | 20.5x | -6.3x | 2.4x |
Price to Earnings Ratio
-6.3x
Current Industry PE
- Investors are pessimistic on the Canadian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare sector?
| CA Market | 0.99% | |
| Healthcare | 4.18% | |
| Life Sciences | 19.54% | |
| Pharma | 11.08% | |
| Healthtech | 4.53% | |
| Healthcare Services | 1.52% | |
| Medical Equipment | -5.64% | |
| Biotech | -12.49% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 45.9%, which is higher than its past year's earnings growth of 27.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 47% over the next 5 years.
- This is better than its past earnings decline of 36% per year.
- In contrast, the Life Sciences industry is expected to see its earnings decline by 47% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GTII Green Thumb Industries | CA$8.25 | 6.3% +CA$113.7m | -48.8% | PE27.7x | |
| CURA Curaleaf Holdings | CA$1.38 | 7.0% +CA$77.6m | -76.7% | PS0.6x | |
| NGEN NervGen Pharma | CA$3.97 | 11.8% +CA$30.6m | 33.2% | PB208.1x | |
| VREO Vireo Growth | CA$0.62 | 5.1% +CA$28.6m | -1.6% | PS4.3x | |
| SONA Sona Nanotech | CA$0.79 | 46.3% +CA$28.1m | 163.3% | PB87.8x |
